These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 43303)
41. [The tenth conference on emergencies and severe complication in cancer patients]. Sculier JP; Berghmans T; Meert AP Rev Med Brux; 2010; 31(1):61-2. PubMed ID: 20384054 [No Abstract] [Full Text] [Related]
42. Growing up healthy, afterward. Kalb C Newsweek; 2003 Dec; 142(23):74. PubMed ID: 14712568 [No Abstract] [Full Text] [Related]
43. Interactions of chemotherapy and radiation. Vokes EE Semin Oncol; 1993 Feb; 20(1):70-9. PubMed ID: 8475412 [No Abstract] [Full Text] [Related]
44. Combination chemotherapy--theory and practice. Capizzi RL; Keiser LW; Sartorelli AC Semin Oncol; 1977 Jun; 4(2):227-53. PubMed ID: 327555 [No Abstract] [Full Text] [Related]
45. An outline of cancer chemotherapy. Connors TA Rev Roum Inframicrobiol; 1971; 8(3):135-51. PubMed ID: 5152643 [No Abstract] [Full Text] [Related]
49. Combined action of irradiation and chemotherapy on transplantable tumors in the rat. Barendsen GW Can J Otolaryngol; 1975; 4(1):26-31. PubMed ID: 1131723 [No Abstract] [Full Text] [Related]
50. [Combined treatment of malignant tumors of the otolaryngological area with directed administration of cytostatics and roentgen irradiation]. Uchytil B; Bzonek J; Mechl Z; Konecný M Cesk Otolaryngol; 1965 Jun; 14(3):132-9. PubMed ID: 5837827 [No Abstract] [Full Text] [Related]
51. Screening data from the Cancer Chemotherapy National Service Center screening laboratories. XXXIX. Plant extracts. Abbott BJ; Hartwell JL; Leiter J; Perdue RE; Price JR; Schepartz SA Cancer Res; 1967 Feb; 27(2 Pt 2):1-171. PubMed ID: 4289484 [No Abstract] [Full Text] [Related]
52. Planning combined therapy--the interaction of experimental and clinical studies. Carter SK Cancer Chemother Rep 2; 1974 Mar; 4(1):3-11. PubMed ID: 4826498 [No Abstract] [Full Text] [Related]
53. Proceedings of the International Conference on Enzyme Pattern-Targeted Chemotherapy. Titisee, West Germany, May 2, 3 and 4, 1985. Adv Enzyme Regul; 1985; 24():1-489. PubMed ID: 3835817 [No Abstract] [Full Text] [Related]
54. Proceedings of the Wellcome Foundation--British Association of Surgical Oncology. Symposium on Cancer Chemotherapy: New Potential for Established Drugs? London, England, 22-23 February, 1979. Cancer Treat Rev; 1979 Jun; 6 Suppl():1-150. PubMed ID: 40696 [No Abstract] [Full Text] [Related]
55. Immunotherapeutic strategies for neoplasia. Talmadge JE Dev Biol Stand; 1992; 77():17-28. PubMed ID: 1426659 [No Abstract] [Full Text] [Related]
57. Modification of radiotherapy by radiosensitizers and cancer chemotherapy agents. I. Radiosensitizers. Coleman CN Semin Oncol; 1989 Jun; 16(3):169-75. PubMed ID: 2658080 [No Abstract] [Full Text] [Related]
58. [Calreticulin dictates the immunogenicity of anti-cancer chemotherapy and radiotherapy]. Apetoh L; Ghiringhelli F; Zitvogel L Med Sci (Paris); 2007 Mar; 23(3):257-8. PubMed ID: 17349284 [No Abstract] [Full Text] [Related]
59. [Introduction of new screening system in National Cancer Institute]. Tsukagoshi S Gan To Kagaku Ryoho; 1984 May; 11(5):1134-9. PubMed ID: 6539100 [No Abstract] [Full Text] [Related]
60. Cost savings in cancer care from the selection of effective versus ineffective initial chemotherapy. Dickinson KD; Myers TJ Prog Clin Biol Res; 1990; 339():465-76. PubMed ID: 2118261 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]